openPR Logo
Press release

Pharmaceutical Intermediates Market Opportunity Assessment Research Study

03-06-2018 12:24 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Pharmaceutical Intermediates Market Opportunity Assessment

Pharmaceutical intermediates are the chemical compounds that are the building blocks used in the production of active pharmaceutical ingredients. Pharmaceutical intermediates are produced during the process of manufacturing or synthesis of active pharmaceutical ingredients. These pharmaceutical intermediates further undergo molecular changes and processing before becoming an active pharmaceutical ingredient.

Pharmaceutical intermediates market is very dynamic market. Pharmaceutical industry is one of the fastest growing industry and since, the pharmaceutical intermediates are building blocks of APIs so with the growth of industry, pharmaceutical intermediates market is also expected to grow. Over the past few years there has been a major shift towards the research and with the growth in the research industry, pharmaceutical intermediate market is also expected to show a significant growth. Increasing economic pressure as well increasing regulatory barriers are expected to stall the growth of pharmaceutical intermediates market.

Global pharmaceutical intermediates market is expected to show significant growth over the forecast period. Greater production of active pharmaceutical ingredients are expected to enhance the demand of pharmaceutical intermediates. Prevalence of life style disease is increasing and along with that geriatric population is also increasing that is vulnerable to disease. With the increase in prevalence of disease, requirement of drug will increase along with increasing the market of pharmaceutical intermediates. Patent expiration is also one of the key factor driving the overall growth of the generics drug market.

Thus, increasing generic drug is expected to fuel the production of active pharmaceutical ingredients which in turn is expected to fuel the growth of pharmaceutical intermediates market. Pharmaceutical intermediates market is dominated by pharmaceutical companies and is expected to continue to be dominated by pharmaceutical companies over the forecast period. Increase in the research in the pharmaceutical industry is expected to drive the growth for the research labs.

Request For Report sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4515


Geographically, the global pharmaceutical intermediates market can be segmented into: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa. North America is biggest and most attractive market for the pharmaceutical ingredients market due to the presence of major pharmaceutical companies and better infrastructure. North America is expected to continue to dominate the global pharmaceutical intermediates market over the forecast period. Asia Pacific is expected to be fastest growing pharmaceutical intermediates market due to presence of large number of contract manufacturing organization in the region. Asia Pacific region is dominated by the China and Japan who among biggest pharmaceutical market. Other regions such as Latin America is also expected to show a significant growth in the pharmaceutical intermediates market due to increasing consumption of pharmaceutical products.

Some of the major players in the global pharmaceutical intermediates market are, Aceto Corporation, Easter Chemical Corporation, BASF SE, Midas Pharma GmbH, A.R. Life Sciences Private Limited, Lianhetech, Dishman Group, Codexis, Cycle Pharma Chem, Sanofi Winthrop Industries, Vertellus Holdings LLC, Dextra Laboratories Limited, Chemcon Specialty Chemical Pvt. Ltd., and ZCL Chemical Ltd. These companies are majorly focusing on collaboration and merges & acquisition strategies to increase their market shares and expand into new regions and specialty. Majority of the pharmaceutical companies are focusing on outsourcing pharmaceutical intermediates from contract manufacturing organizations to reduce the cost.

Request For Table Of Content @ https://www.futuremarketinsights.com/toc/rep-gb-4515

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes,technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends. technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Future Market Insights
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaceutical Intermediates Market Opportunity Assessment Research Study here

News-ID: 966414 • Views:

More Releases from Future Market Insights

Global Olive Stone Coffee and Beverage Roasts Market to Reach USD 1,620 Million by 2036 as Sustainable Specialty Brewing Gains Momentum
Global Olive Stone Coffee and Beverage Roasts Market to Reach USD 1,620 Million …
The global olive stone coffee and beverage roasts market is entering a high-growth decade, fueled by sustainability innovation and evolving specialty coffee culture. Valued at USD 510 million in 2026, the market is projected to reach USD 1,620 million by 2036, expanding at a compelling CAGR of 11.5%. As consumers increasingly seek beverages that combine sustainability, functionality, and distinctive taste, olive stone-based roasting solutions are transitioning from niche experimentation to structured
Japan Dried Spent Grain Market to Surpass USD 1.1 Billion by 2036 as Feed Optimization and Fiber-Rich Food Innovation Sustain Growth
Japan Dried Spent Grain Market to Surpass USD 1.1 Billion by 2036 as Feed Optimi …
Japan's dried spent grain market is entering a decade of steady, value-driven expansion, supported by structured feed demand, brewery byproduct utilization, and rising integration of fiber-rich ingredients into food manufacturing. Industry estimates place the market at USD 784.8 million in 2026, with projections indicating growth to USD 1,109.4 million by 2036, reflecting a CAGR of 3.5%. Between 2020 and 2026, demand increased from USD 637.5 million to USD 784.8 million, shaped
USA Food Grade Titanium Dioxide Market to Reach USD 7.3 Million by 2036 Amid Steady Regulatory-Aligned Demand
USA Food Grade Titanium Dioxide Market to Reach USD 7.3 Million by 2036 Amid Ste …
The demand for food grade titanium dioxide in the USA is valued at USD 4.9 million in 2026 and is projected to reach USD 7.3 million by 2036, expanding at a CAGR of 4.1%. Growth remains moderate yet stable, supported by continued use of titanium dioxide as a whitening and opacifying agent across confectionery coatings, bakery decorations, sauces, dairy analogues, and processed food matrices. Despite heightened regulatory scrutiny and evolving clean-label
USA Partially Hydrogenated Oil Market to Reach USD 529.4 Million by 2036 Amid Measured Industrial and Specialty Food Demand
USA Partially Hydrogenated Oil Market to Reach USD 529.4 Million by 2036 Amid Me …
The demand for partially hydrogenated oil in the USA is projected to rise from USD 309.6 million in 2026 to USD 529.4 million by 2036, expanding at a steady CAGR of 5.5%. While edible applications remain tightly regulated, demand persists across specialty industrial and permitted food-related segments where oxidative stability, viscosity control, and texture performance remain critical. Despite regulatory constraints on trans fats in conventional food manufacturing, PHOs continue to serve

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the